EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Pharmaresearch Bio Co's enterprise value is ₩97,210 Mil.
Pharmaresearch Bio Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₩20,031 Mil. Therefore, Pharmaresearch Bio Co's EV-to-Revenue for today is 4.85.
The historical rank and industry rank for Pharmaresearch Bio Co's EV-to-Revenue or its related term are showing as below:
XKRX:217950'
s EV-to-Revenue Range Over the Past 10 Years
Min: 3.15 Med: 10.2 Max: 24.94
Current: 4.85
During the past 6 years, the highest EV-to-Revenue of Pharmaresearch Bio Co was 24.94. The lowest was 3.15. And the median was 10.20.
XKRX:217950's EV-to-Revenue is ranked better than 62.91% of 1038
companies
in the Biotechnology industry
Industry Median: 8.145
vs XKRX:217950: 4.85
Pharmaresearch Bio Co EV-to-Revenue Historical Data
The historical data trend for Pharmaresearch Bio Co's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Pharmaresearch Bio Co's EV-to-Revenue
For the Biotechnology subindustry, Pharmaresearch Bio Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharmaresearch Bio Co's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Pharmaresearch Bio Co's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Pharmaresearch Bio Co's EV-to-Revenue falls into.
Pharmaresearch Bio Co's current Enterprise Value is ₩97,210 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Pharmaresearch Bio Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₩20,031 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharmaresearch Bio Co (XKRX:217950) EV-to-Revenue Explanation
Pharmaresearch Bio Co's share price for today is ₩28400.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was ₩4,937.30.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharmaresearch Bio Co EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Pharmaresearch Bio Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Pharmaresearch Bio Co (XKRX:217950) Business Description
Pharmaresearch Bio Co Ltd is a Korea-based biopharmaceutical company. The company is engaged in the research and development, manufacturing, sale, and marketing of biopharmaceutical products. Its product is ReNTox Injections, and Clostridium Botulinum Toxin type A is in pipeline.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:217950 has been successfully added to your